A patient preference study comparing raltitrexed (‘Tomudex’) and bolus or infusional 5-fluorouracil regimens in advanced colorectal cancer: influence of side-effects and administration attributes

This publication has 21 references indexed in Scilit:

• Agency in health care. Examining patients' preferences for attributes of the doctor–patient relationship
  Journal of Health Economics, 1998
• Assessing patients' needs and preferences in the management of advanced colorectal cancer.
  British Journal of Cancer, 1998
• Raltitrexed
  Drugs, 1998
• Final results of a randomised trial comparing ‘Tomudex’® (raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer
  Annals of Oncology, 1996
• Tradeoffs between Quality and Quantity of Life
  Medical Decision Making, 1996
• Cancer patients, doctors and nurses vary in their willingness to undertake cancer chemotherapy
  European Journal Of Cancer, 1995
• Breast Cancer Patients' Perceived Participation in Health Care: How Do Patients Themselves and Nurses Assess this Participation?
  Nursing Ethics, 1994
• Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public.
  BMJ, 1990
• High-dose folinic acid and 5-fluorouracil bolus and continuous infusion in advanced colorectal cancer
  European Journal of Cancer and Clinical Oncology, 1988
• Considerations guiding physicians when informing cancer patients
  Social Science & Medicine, 1987